Immunitybio
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $26,425 | $16,517 | $7,552 | $6,106 |
Gross Profit | 26,289 | 16,459 | 7,552 | 6,106 |
EBITDA | -59,541 | -64,429 | -17,451 | -41,066 |
EBIT | -63,421 | -68,258 | -21,605 | -45,505 |
Net Income | -92,555 | -129,646 | -59,162 | -85,729 |
Net Change In Cash | 26,425 | 16,517 | 7,552 | 6,106 |
Free Cash Flow | -80,827 | -87,026 | -87,255 | -101,555 |
Cash | 137,658 | 60,660 | 143,428 | 111,966 |
Basic Shares | 888,216 | 853,162 | 700,443 | 697,961 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $14,745 | $622 | $240 | $934 |
Gross Profit | 14,745 | 622 | -23,952 | 934 |
EBITDA | -241,764 | -436,182 | -335,511 | -315,380 |
EBIT | -259,318 | -454,694 | -359,703 | -334,502 |
Net Income | -413,564 | -583,196 | -417,320 | -349,848 |
Net Change In Cash | 14,745 | 622 | 240 | 934 |
Cost of Revenue | -76,599 | 146,138 | ||
Free Cash Flow | -398,124 | -397,341 | -436,900 | -307,982 |
Cash | 143,428 | 265,453 | 104,641 | 181,101 |
Basic Shares | 700,443 | 508,635 | 399,900 | 389,234 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.10 |
2025-03-31 | -$0.15 |
2024-12-31 | -$0.08 |
